Caprelsa (vandetanib)

pCPA File Number: 20906
Negotiation Status:
Concluded without agreement
Indication(s):
Medullary Thyroid Cancer
Sponsor/Manufacturer:
Sanofi Genzyme Canada
CDA-AMC Project Number:
PC0090-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: